[EN] DIHYDROBENZOFURANYL ALKANAMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br/>[FR] ALCANAMINES DIHYDROBENZOFURANYLE ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
申请人:WYETH CORP
公开号:WO2005040146A1
公开(公告)日:2005-05-06
Compounds of formula (1) or pharmaceutically acceptable salts thereof are provided : Formula (1) which are agonists and partial agonists of the 2c subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, can be used to treat a variety of central nervous system disorders such as schizophrenia.
Dihydrobenzofuranyl alkanamines and methods for using same as cns agents
申请人:Gross Laird Jonathan
公开号:US20050124692A1
公开(公告)日:2005-06-09
Compounds of formula 1 or pharmaceutically acceptable salts thereof are provided:
which are agonists and partial agonists of the 2c subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, can be used to treat a variety of central nervous system disorders such as schizophrenia.
DIHYDROBENZOFURANYL ALKANAMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
申请人:Wyeth
公开号:EP1675842A1
公开(公告)日:2006-07-05
US7728155B2
申请人:——
公开号:US7728155B2
公开(公告)日:2010-06-01
Phase-Transfer Catalyzed Nucleophilic Addition of Arylalkanenitrile Carbanions to Substituted Propenylarenes
作者:Wojciech Lasek、Mieczysław Makosza
DOI:10.1055/s-1993-35865
日期:——
Phenylacetonitrile and 2-phenylalkanenitriles react under phase transfer catalysis conditions with 2-propenylanisoles containing electron-withdrawing substituents (or their corresponding precursors, 2-allylanisoles) via the Michael addition pathway to give substituted 4-aryl-2-phenylbutyronitriles.